Cargando…
The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
Osteosarcoma (OS) is a high-grade malignant stromal tumor composed of mesenchymal cells producing osteoid and immature bone, with a peak of incidence in the second decade of life. Hence, although relatively rare, the social impact of this neoplasm is particularly relevant. Differently from carcinoma...
Autores principales: | Cascini, Caterina, Chiodoni, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304628/ https://www.ncbi.nlm.nih.gov/pubmed/34359840 http://dx.doi.org/10.3390/cells10071668 |
Ejemplares similares
-
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023) -
Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy
por: Perrone, Milena, et al.
Publicado: (2021) -
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022) -
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response
por: Liu, Dong, et al.
Publicado: (2023) -
Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma
por: Yang, Liyu, et al.
Publicado: (2023)